Skip to main content
University of Washington UW W Logo Engineering Innovation in Health Wordmark Logo

Industry

Industry involvement

Engineering Innovation in Health (EIH) develops technical solutions to pressing challenges in health. We welcome projects from your company that will benefit from a collaborative working team of industry professionals, UW students, and faculty.

Benefits

By participating in EIH, you have the opportunity to:

  • Develop innovative technical solutions that bring value to your company.
  • Vet a solution to a challenging problem, perhaps one that you don’t have the resources to pursue in-house.
  • Generate a deeper understanding of a health challenge, market, current solutions, intellectual property, and regulatory strategy that engages a comprehensive set of stakeholders.
  • Work closely with a diverse group of UW students and faculty from engineering, health sciences, and business.
  • Strengthen your relationship with the UW for recruiting student talent and for engaging in future projects.
  • Leverage world class infrastructure and facilities at UW.
  • Receive a nonexclusive commercial license to any project intellectual property developed by the student team or UW employees.

Involvement

The Engineering Innovation in Health program runs for 9 months. Projects typically start in the fall (October) and run for three quarters (ending in June).

Participating companies pay a sponsorship fee and designate an employee lead to mentor the team. The mentor meets with the team weekly to help them understand the problem in depth and guide the solution pathway.

Intellectual property is governed by existing federal and state laws and is subject to best practices of the University of Washington technology transfer office, CoMotion. A company wholly owns its existing intellectual property. A nonexclusive, commercial license will be granted to any project intellectual property developed by the student team or UW employees. Additional, pre-negotiated options for exclusive licenses have been standardized as part of the Washington Innovation Advantage Program.

The EIH process starts with industry sponsors or clinicians submitting a project idea that focuses on an unmet health challenge and ultimately ends with a working prototype solution, which can take the form of a device, process, or application. Project submissions are due on a rolling basis between May and August each year. We welcome you to reach out to us and discuss your ideas. Please contact EIHealth@uw.edu to learn more.

 

Submit a health challenge

 

Sample projects

For a full list of previous projects, visit the Projects section.

SaniClaw: Easing Germicidal Wipe Dispensing in Health Care Facilities »

Hospital-acquired infections (HAIs) compromise provider care and treatment, add to unreimbursed financial burden, and could lead to life-threatening events. While all items and surfaces in the clinical care setting need to be wiped down with germicidal wipes, the wipes are a challenge to dispense and the dispensers themselves are often covered in pathogens. SaniClaw is a disposable claw that assists in threading the initial wipe and was designed with key features to prevent accumulation of pathogens on the dispenser and ultimately curb the incidence of infections.

Enteroatmospheric Fistula Isolation »

An enteroatmospheric fistula (EAF) is a hole between the gastrointestinal tract and an unhealed wound, and thus the open air. Between 1,000 and 4,000 cases occur annually in the United States, with a mortality rate of over 40%. EAF leak interstitial fluid into the wound, which hampers the healing process. Current methods to heal the abdominal wounds surrounding EAF are time consuming to install and don’t last long. This fistula isolation device is easy to install, stays in place once installed thanks to the silicone microbeads that fill it, and allows fluid to flow out of the body without irritating the wound bed.

Enteroatmospheric fistula isolation device

EquinOx »

Blood oxygen saturation measurements are recorded over 800 million times in the US on a wide range of patients. But studies show that pulse oximeters are 3 times less accurate in black patients than in white ones; pulse oximeters missed hypoxemia (when Sp 02 levels are less than 88%) at a rate of 11.7% in Black patients versus 3.6% in white patients. This highlights the need for a way to reduce pulse oximeter inaccuracies so a simple, minimally invasive, and accurate method to measure O2 levels is available for patients with darker skin tones. The EquinOx pulse oximeter plan includes a skin tone sensor and correction algorithm that allows the user to get a more accurate reading, regardless of skin tone. 

 

EquinOx